Literature DB >> 12736047

Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens.

Barbara W Trautner1, Richard A Hull, Rabih O Darouiche.   

Abstract

OBJECTIVES: The presence of a nonpathogenic organism on the surface of a urinary catheter might impede catheter colonization by pathogens and thus prevent urinary tract infection. Previously, we reported that preinoculating urinary catheters with a nonpathogenic strain of Escherichia coli (83972) significantly impeded catheter colonization in vitro by gram-positive bacteria (Enterococcus faecalis). To explore this phenomenon further, we investigated in vitro whether E. coli 83972 could likewise inhibit catheter colonization by gram-negative and fungal uropathogens (Providencia stuartii, uropathogenic E. coli, and Candida albicans).
METHODS: For each of the three uropathogens tested, we examined three different incubation conditions: (a) E. coli plus uropathogen catheters were exposed to E. coli 83972 for 24 hours and then to a uropathogen for 30 minutes; (b) E. coli-alone catheters were incubated with E. coli for 24 hours and then in sterile broth for 30 minutes; and (c) uropathogen-alone catheters were incubated in sterile broth for 24 hours before the 30-minute incubation with the uropathogen. All catheters were subsequently incubated in sterile human urine for 24 hours. Catheters were then rinsed and sonicated to determine the numbers of adherent organisms per centimeter.
RESULTS: Pre-exposure of the catheter to E. coli 83972 in all cases significantly reduced the number of uropathogens colonizing the catheter surfaces.
CONCLUSIONS: E. coli 83972 significantly impedes catheter colonization by all tested bacterial and fungal pathogens. The broad applicability of this particular approach to bacterial interference in vitro invites further exploration in vivo.

Entities:  

Mesh:

Year:  2003        PMID: 12736047      PMCID: PMC2963591          DOI: 10.1016/s0090-4295(02)02555-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  25 in total

Review 1.  Biofilm, city of microbes.

Authors:  P Watnick; R Kolter
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.

Authors:  C A Kauffman; J A Vazquez; J D Sobel; H A Gallis; D S McKinsey; A W Karchmer; A M Sugar; P K Sharkey; G J Wise; R Mangi; A Mosher; J Y Lee; W E Dismukes
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

3.  Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.

Authors:  R Hull; D Rudy; W Donovan; C Svanborg; I Wieser; C Stewart; R Darouiche
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

4.  Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury.

Authors:  K B Waites; K C Canupp; E S Brookings; M J DeVivo
Journal:  J Spinal Cord Med       Date:  1999       Impact factor: 1.985

5.  Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis.

Authors:  Barbara W Trautner; Rabih O Darouiche; Richard A Hull; Sheila Hull; John I Thornby
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

6.  A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters.

Authors:  J W Warren; J H Tenney; J M Hoopes; H L Muncie; W C Anthony
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

7.  Lactobacillus coryniformis subsp. coryniformis strain Si3 produces a broad-spectrum proteinaceous antifungal compound.

Authors:  J Magnusson; J Schnürer
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

8.  Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells.

Authors:  J Osset; R M Bartolomé; E García; A Andreu
Journal:  J Infect Dis       Date:  2000-12-29       Impact factor: 5.226

9.  Pilot trial of bacterial interference for preventing urinary tract infection.

Authors:  R O Darouiche; W H Donovan; M Del Terzo; J I Thornby; D C Rudy; R A Hull
Journal:  Urology       Date:  2001-09       Impact factor: 2.649

Review 10.  Bacterial interference for prevention of urinary tract infection: an overview.

Authors:  R O Darouiche; R A Hull
Journal:  J Spinal Cord Med       Date:  2000       Impact factor: 1.985

View more
  25 in total

Review 1.  Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections.

Authors:  Paschalis Vergidis; Robin Patel
Journal:  Infect Dis Clin North Am       Date:  2012-03       Impact factor: 5.982

2.  Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence.

Authors:  Devak G Desai; Kershena S Liao; Manuel E Cevallos; Barbara W Trautner
Journal:  J Urol       Date:  2010-12       Impact factor: 7.450

3.  Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.

Authors:  Per Klemm; Viktoria Roos; Glen C Ulett; Catharina Svanborg; Mark A Schembri
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 4.  Prevention of catheter-associated urinary tract infection.

Authors:  Barbara W Trautner; Richard A Hull; Rabih O Darouiche
Journal:  Curr Opin Infect Dis       Date:  2005-02       Impact factor: 4.915

5.  Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization.

Authors:  Barbara W Trautner; Richard A Hull; John I Thornby; Rabih O Darouiche
Journal:  Infect Control Hosp Epidemiol       Date:  2006-12-29       Impact factor: 3.254

Review 6.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

7.  Biofilms 2007: broadened horizons and new emphases.

Authors:  Robert J Palmer; Paul Stoodley
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

8.  The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine.

Authors:  Viktoria Roos; Glen C Ulett; Mark A Schembri; Per Klemm
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

9.  Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.

Authors:  Susan M Lehman; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

Review 10.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.